Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Depreciation & Amortization (IS): 2009-2015

Historic Depreciation & Amortization (IS) for Northwest Biotherapeutics (NWBO) over the last 4 years, with Mar 2015 value amounting to $3,000.

  • Northwest Biotherapeutics' Depreciation & Amortization (IS) changed negligibly% to $3,000 in Q1 2015 from the same period last year, while for Mar 2015 it was $355,000, marking a year-over-year decrease of 85.20%. This contributed to the annual value of $11,000 for FY2014, which is 8.33% down from last year.
  • Per Northwest Biotherapeutics' latest filing, its Depreciation & Amortization (IS) stood at $3,000 for Q1 2015, which was down 99.13% from $346,000 recorded in Q3 2014.
  • In the past 5 years, Northwest Biotherapeutics' Depreciation & Amortization (IS) registered a high of $2.4 million during Q4 2013, and its lowest value of $2,000 during Q3 2011.
  • In the last 3 years, Northwest Biotherapeutics' Depreciation & Amortization (IS) had a median value of $3,000 in 2015 and averaged $344,125.
  • Examining YoY changes over the last 5 years, Northwest Biotherapeutics' Depreciation & Amortization (IS) showed a top increase of 59,325.00% in 2012 and a maximum decrease of 50.00% in 2012.
  • Quarterly analysis of 5 years shows Northwest Biotherapeutics' Depreciation & Amortization (IS) stood at $4,000 in 2011, then soared by 59,325.00% to $2.4 million in 2012, then climbed by 0.50% to $2.4 million in 2013, then skyrocketed by 11,433.33% to $346,000 in 2014, then remained steady at $3,000 in 2015.
  • Its Depreciation & Amortization (IS) stands at $3,000 for Q1 2015, versus $346,000 for Q3 2014 and $3,000 for Q2 2014.